Efficacy and safety of red ginseng on menopausal symptoms; A 12weeks, Randomized, Doubleblind, Placebo-Controlled Clinical Trial
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, NEC
- Registration Number
- KCT0003879
- Lead Sponsor
- Konkuk University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
1) Women 40 to 65 years of age who are in the menopause (12 months or more)
2) Women with a KMI (kupperman index) score of 20 or higher
3) Women who have agreed to participate in this trial before the start of the clinical trial and who have written an informed consent form
1) Women who have surgical or chemotherapy induced menopause
2) Women who have undergone hysterectomy
3) Women with a history of endometrial hyperplasia, endometrial cancer, breast disease, sex hormone related cancer
4) Patients with uncontrolled hypertension(160/100mmHg or higher, after 10 minutes of clinical test subjects)
5) A woman with a history of severe migraine within the past 1 year, diagnosed with thromboembolism, cerebrovascular disease, myocardial infarction, unstable angina, or coronary angioplasty
6) A person whose ALT and AST exceed 3 times the normal upper limit
7) A person whose Creatinine exceed 2 times the normal upper limit
8) who are not considrered to be appropriate to particiapt on this study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kupperman index
- Secondary Outcome Measures
Name Time Method Climacteric symptoms questionnaire;Anthropometric markers;Safety markers